Src is a non-receptor tyrosine kinase that is deregulated in many types of cancer. Decades of research have revealed the crucial role of Src in many aspects of tumor development, including proliferation, survival, adhesion, migration, invasion and, most importantly, metastasis, in multiple tumor types. Despite extensive preclinical evidence that warrants targeting Src as a promising therapeutic approach for cancer, Src inhibitor(s) showed only minimal therapeutic activity in various types of solid tumors when used as a single agent in recent early-phase clinical trials.
Drug targets for cancer: Src research reagents
Other vital drug targets for cancer likeSrc:
Zhang S, Yu D. Targeting Src family kinases in anti-cancer therapies: turning promise into triumph[J]. Trends in pharmacological sciences, 2012, 33(3): 122-128.